Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cda-2 (1 trial)
Myelodysplastic Syndromes (Phase 4)
Preleukemia (Phase 4)
Syndrome (Phase 4)
Trials (1 total)
Trial APIs (1 total)